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BACKGROUND: Although lazaroids have been shown 
to protect various organs from ischemia/reperfusion 
injury, results obtained in the small intestine have 
been conflicting. 
STUDY DESIGN: The canine small intes:ine was made 
totally ischemic for 2 hours by occluding the superior 
mesenteric artery and the superior mesenteric vein 
with interruption of the mesenteric collateral vessels. 
A lazaroid compound, U74500A, or a citrate vehicle 
was given intravenously to each of the six animals 
for 30 minutes before intestinal ischemia. Intestinal 
tissue blood flow, lipid peroxidation, neutrophil infil-
tration, adenine nucleotides and their catabolites, and 
histologic changes after reperfusion were determined. 
RESULTS: Lazaroid treatment attenuated decline of 
the mucosal and serosal blood flow after reperfusion. 
Accumulation of lipid peroxidation products and neu-
trophils in mucosal tissues was markedly inhibited by 
the treatment. Postischemic energy resynthesis was also 
augmented by lazaroid. Morphologically, mucosal ar-
chitectures were better preserved with lazaroid treat-
ment after reperfusion, and recovered to normal by 
postoperative day 3 in the treated group and by post-
operative day 7 in control aninlals. 
CONCLUSIONS: Lazaroids protect the canine small in-
testine from ischemia/reperfusion injury by inhibiting 
lipid peroxidation and neutrophil infiltration. Dogs 
are tolerant of 2-hour normothermic complete intes-
tinal ischemia. J. Am. Coil. Surg., 1997, 184: 389-396. 
H ICHLY REACI I\T FREE RADICALS derived from the 
reaction of molecular oxygen with xanthine oxi-
dase have been believed to play a major role 
in ischemia/reperfusion injury or the small in-
testine (1). Peroxidation of cellular membranes 
by oxygen radicals has been shown in postis-
Accepted I()r publication Septemher 10, 1996. 
From the Pittsbllrgh Transplantation institllte,'" and the Depart-
Illcnt of Pathologv.' L'ni\'t·rsity of Pittsbllrgh, I'illsburgh, Pa. 
Sllpported in part }" research grants hom the Veterans Admini-
stration and Project Crant \io. DK-29961 frolll the "ational Institnlcs 
of llealth, Bethesda, ;\1<1. 
Correspondence address: Satoru Toclo, MD, 4C Falk Clinic, 3601 
Fifth Avenue, Pittsburgh, PA 15213. 
chemic mucosal tissue using malondialdehyde 
measurement (2), electron-spin resonance, or 
conjugation diene assay (3). In addition, intes-
tinal injury was prevented by various antioxidants, 
such as superoxide dismutase (I), catalase (4), 
allopurinol (1), or a-tocopherol (5). Recently, 
neutrophil activation (6) and reduced nitric oxide 
production (7) have also been shown to be 
associated with intestinal ischemia/reperfusion 
injury. 
Lazaroids, a group of synthetic 21-aminosteroid 
compounds lacking glucocorticoid and miner-
alocorticoid actions (8), are potent antioxidants 
that have been used to protect against ischemia/ 
reperfusion injury of the central nervous system 
(9), heart (10), lung (11), liver (12), and kidney 
(13). Results of the use of lazaroids in cases 
of intestinal ischemia have been conflicting. 
Chen and coworkers (14), Horton and Walker 
(15), Stone and colleagues (16), and Katz and 
associates (17) reported amelioration of mu-
cosal injury with lazaroids, and Park and co-
workers (18) and Van Yc and associates (19) 
found no protection. In the current study, we 
evaluated the effect of lazaroid U745001\ on 
the canine small intestine undergoing 2 hours 
of normothermic ischemia. 
MATERIALS AND METHODS 
Animals. Twelve adult female beagle dogs, 
weighing 7.2 kg to 11.2 kg, were used. After 
overnight fasting, the animals were anesthetized 
with an intravenous injection of 25 mg/kg thio-
pental-sodium, intubated, and maintained with 
isof1urane, nitrous oxide,. and oxygen by positive 
pressure mechanical ventilation. During surgery, 
lactated Ringer's (LR) solution (Baxter, Deer-
field, Ill) was given continuously at a rate of 25 
to 30 mL/kg per hour through the right jugular 
vein. Animal body temperature was maintained 
with a hot water blanket connected to a heat 
therapy pump (Gaymar, Orchard Park, NY). 
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Heart rate, femoral arterial pressure, and esoph-
ageal temperature were continuously monitored 
by a portable patient monitor (Model 514, 
Spacelabs, Redmond, Wash). 
Operative procedures. Two-hour warm ischemia 
of the small intestine was induced by clamping 
both trunks of the superior mesenteric artery 
(SMA) and the superior mesenteric vein (SMV). 
Isolation of the small bowel was performed by 
the technique originally described by Lillehei and 
associates (20) and modified later by us for the 
procurement of intestinal grafts (21). In brief, 
through a midline laparotomy, the entire small 
bowel, except short segments near the ligament 
of Treitz and the ileocecal valve, was isolated 
on a vascular pedicle consisting of the SMA and 
the SM\!. Lymph nodes and connective tissues 
surrounding both vessels were carefully dissected 
and ligated. Immediately before vascular occlu-
sion, the proximal end of the intestine was 
clamped with atraumatic forceps and the distal 
end of the intestine was transected. Complete 
intestinal ischemia was induced 5 minutes after 
injecting 5 V/kg of sodium heparin (Upjohn, 
Kalamazoo, Mich) by occluding both the SMA 
and the SMV with vascular clamps. Ischemia was 
maintained for 2 hours. During intestinal is-
chemia, the abdominal wound was temporarily 
closed to avoid excessive water and heat loss. 
After collecting ileal tissues for biochemical and 
histologic studies, distal intestinal continuity was 
restored by end-to-end anastomosis. One gram 
of cephamandole nafate (Eli Lilly, Indianapolis, 
Ind) was given intraoperatively. 
The dogs were given standard kennel food the 
morning after surgery. Ten milligrams per kilo-
gram of intramuscular ampicillin (Fort Dodge 
Laboratories, Fort Dodge, Iowa) and 500 mL of 
LR solution with 5 percent dextrose were ad-
ministered daily for 7 days after the operation. 
The dogs were brought back to the operating 
room on the third and seventh postoperative days, 
anesthetized, and reexplored to collect ileal tissue 
specimens. On the third postoperative day, the 
ileum was reanastomosed and the dogs were re-
turned to the animal facility. On postoperative 
day 7, the dogs were sacrificed after ileal tissue 
specimens were collected. 
A'xperimental groups. Lazaroid U74500A, supplied 
by the Upjohn Company, was dissolved in a 
citrate buffer vehicle (pH ;).0) at a concentration 
of 2 mg/mL. The agent (lazaroid group: n=6), 
5 mg/kg, or the vehicle (control group: n=6), 
2.5 mL/kg, was given to the dogs through a 
peripheral vein continuously for 30 minutes 
before intestinal ischemia. The investigators were 
blinded to which dogs received lazaroid treatment. 
Intestinal tissue flow. Tissue blood flow of the 
ileal mucosa and serosa were measured with a 
laser doppler flowmeter (ALF21 , Advance Co., 
Tokyo, Japan) before intestinal isolation, after 
drug administration, 60 minutes and 120 minutes 
after the onset of ischemia, and 5 minutes, 15 
minutes, 30 minutes, and 60 minutes after reper-
fusion. The measurement was repeated three 
times on each surface at the antimesenteric site 
of the terminal ileum. 
Histopathology and biochemistry. A portion of 
the distal end of the small intestine, 5 cm long, 
was resected before ischemia; at the end of 2 
hours of ischemia; 15 minutes, 30 minutes, and 
60 minutes after reperfusion; and on postop-
erative days 3 and 7 for biochemical and his-
tologic studies. For histopathologic analysis, tis-
sues were fixed with 10 percent formalin, 
embedded in paraffin, sectioned, and stained 
with hematoxylin-eosin. The severity of mor-
phologic abnormality was evaluated blindly and 
scored according to the Park's classification sys-
tem (22) by a single pathologist. For biochemi-
cal analysis, the mucosal layer was quickly 
scraped with a glass slide, transferred to liquid 
nitrogen, and stored at -70 degrees C until 
levels of lipid peroxide products (LPOP), 
myeloperoxide (MPO), maltase, adenine nu-
cleotides, and purine catabolites were meas-
ured. Lipid peroxide product levels in the tissue 
were estimated as the sum of 4-hydroxy-2(E)-
nonetal (4-HNE) and malondealdehyde (MDA) 
using spectrophotometric kits (LPO-S86, Bon-
nevil Sur Marne, Cedex, France) (2;)). The su-
pernatant of 10 percent homogenate with Tris-
HCI buffer (pH 7.4) was mixed with 
N-methyl-2-phenilindol and methanesulfonic 
acid. The mixture was incubated for 40 minutes 
at 45 degress C, and then placed in an ice 
water slurry for 10 minutes. After centrifugation, 
the supernatant was decanted and its absorbance 
was read at 586 nm. Myeloperoxide was meas-
ured using the fluorospectrophotometric 
method of Krawisz and associates (24). One 
unit of MPO activity was defined as the con-
centration that caused a 1.0 change in optical 
density at 460 nm for 1 minute at 22 degrees 
C. Adenine nucleotides and purine catabolites 
were measured using a Waters HPLC system (Wa-
ters Chromatography Division, Millipore Corp., 
Milford, Mass; Model 510 pumps, Model 484 
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FIG. 1. a, Changes in mucosal tissue flow, and b, serosal tissue flow. *p<O.O?i compared 
with controls. min. Minutes; hr and h, hour; and m, month. 
absorbance module, and Model 717 WISP system) 
(25). The concentrations were monitored at 254 
nm (Waters 484, Tunable Absorbance Detector). 
Protein contents in the homogenates were meas-
ured using the Bio-Rad protein assay kit (Bio-Rad, 
Richmond, Calif) (26). 
Statistics. Data are expressed as mean plus or 
minus standard error of the mean. The Mann-
Whitney U-test was used for comparison between 
the lazaroid and control groups at the same point 
in time. The Wilcoxon signed rank test was used 
for comparison with pre-ischemic values in each 
group. A p value of less than .05 was considered 
significant. 
RESULTS 
Clinical course. No significant hemodynamic 
changes occurred during U74500A or vehicle ad-
ministration. In spite of the use of a heating 
blanket and temporary closure, there was a grad-
ual decline in esophageal body temperature dur-
ing the experiment in both groups. In both 
groups, five of six animals survived the 7-day 
follow-up period. One dog in each group died 
of intussusception on postoperative day 3. Mild 
diarrhea developed postoperatively in all surviving 
dogs, but the dogs remained active during the 
follow-up period. 
Intestinal tissue blood flow. Drug administration 
caused no changes in blood flow at mucosal and 
serosal tissues (Fig. 1). After reperfusion, how-
ever, tissue blood flow was significantly suppressed 
at each measurement site in the control group 
compared to the pre-ischemic values. Lazaroid 
treatment significantly attenuated the decrease 
of mucosal blood flow at 30 minutes (p<.035). 
Tissue blood flow recovered to normal levels 7 
days after surgery in both groups. 
Lipid peroxidation. Reperfusion of the control 
group intestine after 2 hours of warm ischemia 
caused a significant accumulation of LPOP in 
the mucosal tissue. Lipid peroxide product levels 
increased immediately after reperfusion and con-
tinued to increase, reaching twice the pre-is-
chemic level by 60 minutes (Fig. 2a). Lazaroid 
treatment abolished the early increase in LPOP, 
and markedly suppressed further lipid peroxida-
tion. The difference was highly significant between 
the two groups. 
Myeloperoxide. Lazaroid inhibited neutrophil in-
filtration in the intestinal mucosa after reperfu-
sion (Fig. 2b). Tissue activity of MPO in the 
control group increased from 1.06±1.9 U/mg pro-
tein to 4.22±2.7 U/mg protein at 30 minutes 
after reperfusion; that of the lazaroid group 
remained at 2.16±0.5 U/mg protein (p<.025). 
Adenine nucleotides and purine catabolites. Two-
hour warm ischemia induced a significant de-
cline in energy charge (27), adenosine triphos-
phate (ATP) , and adenosine diphosphate in both 
groups. An expected increase in adenosine mo-
nophosphate and hypoxanthine (HX) was also 
seen during ischemia. Reoxygenation allowed 
partial restoration of the high energy phosphates 
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in both groups, but ATP and total adenosine 
nucleotides at 30 minutes were significantly higher 
in the lazaroid group than in the no-treatment 
group (p<.037 and p<.043, respectively). 
derlying lamina propria was more prominent in 
the control group (Fig. 3). The lamina propria 
was typically edematous, and mucosal capillaries 
were dilated and congested, but an active ill-
flammatory component was present. Mter reper-
fusion, these alterations were superseded by 
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FI(; 4 . a, Mucosa in one control grou p animal at 60 minutes after reperfusion. Th ere is 
complete disrup tion and loss of the villi with focal invo lvement o f crypt laye r (Pa rk 's level 6). 
These areas are replaced by necrotic cellula r debris, hemorrhage, and early inflammator y exudate. 
The crypt bases are intact but the crypt e pithelium shows prominent reactive changes. Hema-
toxylin-eosin , original magnification, x lOO. b, Mucosa in o ne of th e lazaroid group animals a t 
60 minutes after reperfusion. The villi are preserved, although they are largely depleted of 
the ir epith elium (Park's level 4). The luminal surface contains sparse necrotic material and 
inflammato ry cells. The crypts, a lthough showing reactive alteratio n , a re intac t. H e matoxylin-eosin, 
original magnification, x lOO. 
greater mucosal injury. Focal or patchy destruc-
tion of the mucosal structure developed in the 
superficial region and involved deeper mucosa 
in some instances. Neutrophilic infiltrates became 
evident, as well as the presence of luminal 
exudate of necrotic de bris and an inflammatory 
exudate. More severe mucosal illjury develo ped 
60 minu tes after reperfusion , showing extension 
of the necrotic area in the control group (Fig. 
4a). These changes were significantly ameliorated 
in the lazaroid group (Figs. 3 and 4b). Mucosal 
alterations were mostly resolved by the third pos t-
operative day, and the mucosa had normal ar-
chitecture with no residual abnormalities by post-
operalive day 7 (Fig. 3). 
DISC USSION 
This study de monstrated that normo thermic 2-
hour ischemia of the canine intes tine callsed se-
vere mucosal damage aft r reperfusio n , causing 
a decline in mucosal tissue flow and sloughing 
of the mucosal layer. The treatment of animals 
with Iazaroid U74500A before in testinal ischemia 
attenuated histologic damage from ischemia/ 
reperfusion by inhibiting lipid peroxida tion and 
neutrophil infiltration in the mucosal tissues. Ir-
respective of the treatme n t, [he dogs tolerated 
2-hour intestinal ischemia rather well, and the 
mucosal structure recov I-ed to normal by post-
operative day 3 in the treated group and by 
postoperative day 7 in the control group. 
Ischemia/ reperfusion injury of the small intes-
tine has been explained by the generation of 
superoxide anions produced from th hypoxan-
thine-xanthine oxidase system (located in the en-
lerocytes of the villus tip and in endothelial cells 
in the microvasculature) a nd the NADPH oxidase 
system in neUiTO( hils . Once generated , supera:-: 
ide an ions promote production of reactive oxygen 
metabolites, such as hydrogen peroxide and hy-
droxyl radicals. Hydroxyl radicals extract a hy-
droge n atom from polyunsaturated fatty acids 
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TABLE I.-MUCOSAL LEVELS OF ADENINE NUCLEOTIDES AND PURINE CATABOLITES 
Reperfusion 
Before ischemia End of ischemiat 5 min 15 min 30 min 60 min 
EC* 
Lazaroid · ............... O.69±O.O3 O.13±O.O2 O.SS±O.ost O.S7±O.02t O.S7±O.OSt O.OS±O.04t Control ................. O.6S±O.03 O.16±O.O2 O.S6±O.06 O.SO±O.ost O.SO±O.ost O.5S±O.06t 
TAN (nmol/mg prot) 
Lazaroid · ............... 47.3±2.4 
Control ................. 46.1±1.9 
ATP (nmol/mg prot) 
Lazaroid · ............... 26.0±2.1 
Control ................. 23.2±1.4 
ADP (nmol/mg prot) 
Lazaroid · ............... 13.2±O.8 
Control ................. 13.0±0.7 
AMP (nmol/mg prot) 
Lazaroid · ............... 8.2±l.O 
Control ................. 1O.0±1.4 
HX (nol/mg prot) 
Lazaroid · ............... O.94±O.13 
Control ................. l.O7±O.13 
*Energy charge (EC=(ATP+ l/2ADP) I (ATP+ADP+AMP». 
tp<.05 compared with pre-ischemia values in each group. 
1p<.05 compared with controls. 
All data are expressed as mean ±SEM. 
32.9±4.4 27.7±3.2t 
26.8±4.9 27.0±3.2t 
1.6±O.6 10.9±1.3t 
1.6±1.l 10.9±2.0t 
4.6±O.6 8.7±l.Ot 
4.9±O.8 7.8±l.Ot 
26.7±4.8 8.4±l.O 
20.3±4.0 9.4±1.6 
4.58±O.40 2.00±O.30t 
3.75±O.75 1.49±O.26 
2S.2±2.7t 
23.2±3.4t 
32.8±1.2tt 
2S.9±2.7t 
27.S±2.3t 
21.8±2.0t 
1O.3±1.4t 13.9±3.4tt 9.0±1.Ot 
7.9±1.7t 8.6±4.0t 9.0±1.Ot 
8.3±1.3t 96±O.7t 9.0±O.7tt 
6.9±O.9t 8.0±O.4t S.9±O.6t 
6.S±O.S 9.4±1.7 9.6±1.8 
6.5±O.S 9.2±2.2 7.1±1.9 
1.34±O.20t 1.58±O.28t 1.29±O.21 
1.59±O.28 1.43±O.17 1.26±O.24 
min, Minutes; TAN, total adenine nucleotides (TAN=ATP+ADP+AMP); prot, protein; ATP, adenosine triphosphate; ADP, adenosine diphosphate; AMP, 
adenosine monophosphate; and HX, hypoxanthine. 
(PUFA) to form lipid radicals (L), which in turn 
react with oxygen to form lipid peroxyl radicals 
(LOO) , lipid hydroperoxide (LOOH), and lipid 
alkoxyl radicals (LO). They all react with PUFA 
to propagate more lipid peroxidation (28). Per-
oxidation of cellular membranes leads to impair-
ment of cellular function and, finally, to cell death. 
In this study, a significant increase in lipid 
peroxidation in the mucosa of intestines in the 
control group after reperfusion was confirmed 
by a new spectrophotometric assay method (23). 
In ischemia/reperfusion experiments, many in-
vestigators used a thiobarbituric acid (TBA) re-
action for the measurement of one of the LPOP, 
MDA. But because the TBA method has been 
reported to be nonspecific and often provides 
inconsistent results (29), a new assay method was 
applied in this study. Using this new method, 
both 4-HNE and MDA levels were measured 
without the use of TBA. Recently, 4-HNE, an-
other LPOP, was found to be more cytotoxic 
than MDA (30) and a potent chemotactic factor 
for neutrophils (31). 
Administration of lazaroid U74500A before in-
testinal ischemia inhibited accumulation of LPOP 
in mucosal tissue after reperfusion. Many studies 
have described the inhibition of ischemia/ reper-
fusion injury by lazaroids in the central nervous 
system (9, 32), heart (10), lung (11), liver (12), 
and kidney (13) in experimental animals and 
in clinical trials. As we have reported, amelioration 
ofischemia/reperfusion injury by lazaroid U74389G, 
another lazaroid compound, allowed successful 
48-hour preservation and transplantation of ca-
nine livers (33). Lazaroids exert their protective 
effect largely from the inhibition of toxic hydroxyl 
radical production by chelating ferrous ions 
(Fe2+) in Harber-Weiss reaction or in Fenton re-
duction of the free radical cascade. Lazaroids 
also inhibit superoxide production (34) and de-
granulation of neutrophils (35). Neutrophils are 
a particularly important factor in ischemia/reper-
fusion injury of the small intestine. Neutrophils 
are recruited in the microvasculature of the 
postischemic tissues by enhanced expression of 
adherence molecules on the surfaces of neutro-
phils and endothelial cells (6). Once activated, 
neutrophils release various cytokines and pro-
teolytic enzymes, which further augment tissue 
injury initiated by ischemia/reperfusion. Admini-
stration of CDll/CDI8 antibody or p-selectin an-
tibody ameliorates ischemia/postreperfusion in-
jury. In this study, MPO activity in the mucosal 
tissue increased in the control group, reflecting 
neutrophil infiltration after reperfusion (24). Laz-
aroid treatment significantly suppressed MPO lev-
els in the mucosal tissue. Because free radicals 
increase levels of leukotrien B4 (35), a potent 
chemotactic substance of neutrophils, lazaroid 
U74500A appears to inhibit neutrophil infiltra-
tion by its antioxidant properties. 
Previously, the effects of lazaroids on ischemia/ 
reperfusion injury of the small intestine have 
been examined only in rat models (14-19). Ac-
cording to these studies, lazaroids inhibit the in-
crease in intestinal permeability after 20-hour 
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cold, 60-minute warm (14), and 20-minute warm 
ischemia (15). Stone and associates (16) showed 
the attenuation of villus abnormalities after 60-
minute warm ischemia by an infusion of 3 mg/kg 
lazaroid U74006F or U7S7I5G prior to reperfu-
sion. Katz and colleagues also reported that in-
fusion of U74389G to the donor (6 mg/kg) and 
recipient rat (3 mg/kg) minimized morphologic 
damage after IS-hour cold preservation and trans-
plantation (17). But, Park and coworkers (1S) 
and Van Ye and associates (IS) found no pro-
tective effect from U74006F (6 mg/kg) against 
histologic damage in 60-minute warm or 5-hour 
cold ischemia (18), or in a lO-minute warm is-
chemia model (19). These inconsistencies might 
be caused by differences in ischemic time, ex-
perimental model, lazaroid compound, and the 
timing and method of drug administration. The 
lazaroid compound and dose (lazaroid U74500A 
at a dose of 5 mg/kg) was chosen because it 
was found to be more protective in a 2-hour 
canine liver ischemia model than other lazaroid 
compounds (36). 
Although the intestine is susceptible to insult 
from ischemia/ reperfusion (37), the canine small 
bowel appears to be more resistant to ischemia 
than is the rat small bowel. While Hill and as-
sociates (38) reported an SO-percent mortality 
rate after I-hour normothermic intestinal is-
chemia in rats, Lillehei and associates (20) de-
scribed eight of ten dogs that survived 2-hour 
intestinal ischemia. The markedly high activity 
of xanthine oxidase in the rat intestine may ex-
plain the difference (39). Although the canine 
intestine is rather tolerant of normothermic 
ischemia (40, 41), a potent antioxidant, lazaroid 
U74500A, could not prevent ischemia/reperfu-
sion injury completely. While mucosal damage 
was less severe, treated animals still showed his-
tologic derangements, a gradual decrease in mu-
cosal tissue flow, and slow accmTlulation of neu-
trophils. 
Our results suggest that the mechanism of in-
testinal ischemia/reperfusion injury is multifac-
torial, involving not only reactive oxygen meta-
bolites, but also luminal proteolytic enzymes, 
neutrophils, nitric oxide (7), endothelin, pros-
taglandins, and other agents. Delineation of the 
mechanism and invention of a new therapeutic 
strategy for protection against intestinal ischemia/ 
reperfusion injury, which are currently under 
study at our laboratory, will serve to improve 
intestinal preservation and patient treatment. 
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